Rajat J Kudchadker
Overview
Explore the profile of Rajat J Kudchadker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohamad O, Kouzi Z, Kouzy R, Choi S, Mok H, Hoffman K, et al.
Brachytherapy
. 2025 Mar;
24(2):301-309.
PMID: 40024668
Purpose: Brachytherapy boost improves biochemical control for patients with prostate cancer. Here, we report the safety and early efficacy of proton therapy (PT) with a low-dose-rate (LDR) brachytherapy boost. Methods:...
2.
Buyyounouski M, Pugh S, Chen R, Mann M, Kudchadker R, Konski A, et al.
JAMA Oncol
. 2024 Mar;
10(5):584-591.
PMID: 38483412
Importance: No prior trial has compared hypofractionated postprostatectomy radiotherapy (HYPORT) to conventionally fractionated postprostatectomy (COPORT) in patients primarily treated with prostatectomy. Objective: To determine if HYPORT is noninferior to COPORT...
3.
Katlowitz K, Beckham T, Kudchadker R, Wefel J, Elamin Y, Weinberg J
Adv Radiat Oncol
. 2024 Feb;
9(2):101349.
PMID: 38405307
No abstract available.
4.
Wang L, Sanders J, Ward J, Lee S, Poenisch F, Swanson D, et al.
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339376
Background: Current fiducial markers (FMs) in external-beam radiotherapy (EBRT) for prostate cancer (PCa) cannot be positively visualized on magnetic resonance imaging (MRI) and create dose perturbation and significant imaging artifacts...
5.
Sanders J, Tang C, Kudchadker R, Venkatesan A, Mok H, Hanania A, et al.
Brachytherapy
. 2023 Sep;
22(6):822-832.
PMID: 37716820
Purpose: Uncertainties in postimplant quality assessment (QA) for low-dose-rate prostate brachytherapy (LDRPBT) are introduced at two steps: seed localization and contouring. We quantified how interobserver variability (IoV) introduced in both...
6.
Grover S, Lichter K, Likhacheva A, Jang J, Ning M, Robin T, et al.
Brachytherapy
. 2023 Sep;
22(6):716-727.
PMID: 37704540
Purpose: The global cervical cancer burden is disproportionately high in low- and middle-income countries (LMICs), and outcomes can be governed by the accessibility of appropriate screening and treatment. High-dose-rate (HDR)...
7.
Lukka H, Deshmukh S, Bruner D, Bahary J, Lawton C, Efstathiou J, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jan;
116(4):770-778.
PMID: 36592721
Purpose: There is considerable interest in very short (ultrahypofractionated) radiation therapy regimens to treat prostate cancer based on potential radiobiological advantages, patient convenience, and resource allocation benefits. Our objective is...
8.
Gao S, Muruganandham M, Du W, Ohrt J, Kudchadker R, Balter P
J Appl Clin Med Phys
. 2022 May;
23(7):e13633.
PMID: 35533212
Purpose: To better meet clinical needs and facilitate optimal treatment planning, we added two new electron energy beams (7 and 11 MeV) to two Varian TrueBeam linacs. Methods: We worked...
9.
Sanders J, Kudchadker R, Tang C, Mok H, Venkatesan A, Thames H, et al.
Radiol Artif Intell
. 2022 Apr;
4(2):e210151.
PMID: 35391775
The segmentation of the prostate and surrounding organs at risk (OARs) is a necessary workflow step for performing dose-volume histogram analyses of prostate radiation therapy procedures. Low-dose-rate prostate brachytherapy (LDRPBT)...
10.
Sanders J, Mok H, Hanania A, Venkatesan A, Tang C, Bruno T, et al.
Radiother Oncol
. 2022 Jan;
169:132-139.
PMID: 34979213
Background And Purpose: Comparing deep learning (DL) algorithms to human interobserver variability, one of the largest sources of noise in human-performed annotations, is necessary to inform the clinical application, use,...